Citigroup Issues Pessimistic Forecast for H.B. Fuller (NYSE:FUL) Stock Price

H.B. Fuller (NYSE:FUL - Get Free Report) had its price target decreased by research analysts at Citigroup from $85.00 to $78.00 in a report released on Wednesday,Benzinga reports. The firm presently has a "neutral" rating on the specialty chemicals company's stock. Citigroup's price objective suggests a potential upside of 11.73% from the company's previous close.

Separately, StockNews.com downgraded shares of H.B. Fuller from a "buy" rating to a "hold" rating in a research note on Wednesday, September 18th. Three equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of "Hold" and an average target price of $92.75.

H.B. Fuller Trading Down 3.0 %

H.B. Fuller stock traded down $2.16 during mid-day trading on Wednesday, hitting $69.81. The stock had a trading volume of 374,945 shares, compared to its average volume of 298,497. The stock has a 50-day simple moving average of $75.87 and a two-hundred day simple moving average of $78.67. The company has a current ratio of 1.89, a quick ratio of 1.16 and a debt-to-equity ratio of 1.10. The stock has a market capitalization of $3.81 billion, a PE ratio of 21.55, a P/E/G ratio of 1.25 and a beta of 1.41. H.B. Fuller has a 12 month low of $69.34 and a 12 month high of $87.67.

H.B. Fuller (NYSE:FUL - Get Free Report) last issued its quarterly earnings results on Wednesday, September 25th. The specialty chemicals company reported $1.13 EPS for the quarter, missing the consensus estimate of $1.23 by ($0.10). H.B. Fuller had a return on equity of 13.39% and a net margin of 5.15%. The business had revenue of $917.93 million for the quarter, compared to analyst estimates of $944.04 million. During the same quarter in the prior year, the firm earned $1.06 EPS. The firm's quarterly revenue was up 1.9% compared to the same quarter last year. As a group, sell-side analysts forecast that H.B. Fuller will post 4.17 EPS for the current year.

Institutional Investors Weigh In On H.B. Fuller

Several hedge funds have recently added to or reduced their stakes in FUL. New York State Teachers Retirement System grew its stake in H.B. Fuller by 3.1% in the 2nd quarter. New York State Teachers Retirement System now owns 88,348 shares of the specialty chemicals company's stock valued at $6,799,000 after buying an additional 2,694 shares during the last quarter. Bank of New York Mellon Corp boosted its holdings in shares of H.B. Fuller by 1.4% during the second quarter. Bank of New York Mellon Corp now owns 525,731 shares of the specialty chemicals company's stock worth $40,460,000 after acquiring an additional 7,292 shares during the period. Dorsey & Whitney Trust CO LLC grew its position in shares of H.B. Fuller by 8.1% in the second quarter. Dorsey & Whitney Trust CO LLC now owns 71,354 shares of the specialty chemicals company's stock valued at $5,491,000 after purchasing an additional 5,356 shares during the last quarter. Marshall Wace LLP increased its stake in shares of H.B. Fuller by 9.9% during the second quarter. Marshall Wace LLP now owns 290,005 shares of the specialty chemicals company's stock worth $22,319,000 after purchasing an additional 26,239 shares during the period. Finally, S&CO Inc. lifted its holdings in H.B. Fuller by 0.3% during the 3rd quarter. S&CO Inc. now owns 267,192 shares of the specialty chemicals company's stock worth $21,209,000 after purchasing an additional 920 shares during the last quarter. Institutional investors and hedge funds own 95.93% of the company's stock.

H.B. Fuller Company Profile

H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, additives, and other specialty chemical products. It operates through three segments: Hygiene, Health and Consumable Adhesives; Engineering Adhesives; and Construction Adhesives.